Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Efficacy and safety of recaticimab in lowering atherogenic lipids in patients with and without coronary artery disease: a patient-level pooled analysis

Patients with coronary artery disease (CAD) are at very high risk of recurrent cardiovascular events and require intensive lipid-lowering therapy to achieve guideline-recommended targets. Recaticimab is a long-acting anti-PCSK9 monoclonal antibody that has demonstrated significant lipid-lowering efficacy in patie...

C. Li, T. Wu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.